Authors: Krol, ADG Le Cessie, S Snijder, S Kluin-Nelemans, JC Kluin, PM Noordijk, EM

Citation: Adg. Krol et al., Waldeyer's ring lymphomas: A clinical study from the comprehensive cancer center west population based NHL registry, LEUK LYMPH, 42(5), 2001, pp. 1005-1013

Authors: Krol, ADG Berenschot, HWA Doekharan, D Henzen-Logmans, S van der Holt, B van 't Veer, MB

Citation: Adg. Krol et al., Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy andradiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy, RADIOTH ONC, 58(3), 2001, pp. 251-255

Authors: Hoeve, MA Krol, ADG Philippo, K Derksen, PWB Veenendaal, RA Schuuring, E Kluin, PM van Krieken, JHJM

Citation: Ma. Hoeve et al., Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction, J CL PATH-M, 53(4), 2000, pp. 194-200

Authors: van Leeuwen, FE Klokman, WJ van't Veer, MB Hagenbeek, A Krol, ADG Vetter, UAO Schaapveld, M van Heerde, P Burgers, JMV Somers, R Aleman, BMP

Citation: Fe. Van Leeuwen et al., Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood, J CL ONCOL, 18(3), 2000, pp. 487-497

Authors: Koper, PCM Stroom, JC van Putten, WLJ Korevaar, GA Heijmen, BJM Wijnmaalen, A Jansen, PP Hanssens, PEJ Griep, C Krol, ADG Samson, MJ Levendag, PC

Citation: Pcm. Koper et al., Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomizedstudy, INT J RAD O, 43(4), 1999, pp. 727-734

Authors: Senan, S de Koste, JV Samson, M Tankink, H Jansen, P Nowak, PJCM Krol, ADG Schmitz, P Lagerwaard, FJ

Citation: S. Senan et al., Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer, RADIOTH ONC, 53(3), 1999, pp. 247-255